ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 648365 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 648365; 2) Community: the network communities that were significantly associated with the response to NSC 648365; 3) Molecule: the relationships between components within communities and NSC 648365; 4) MDR: the compounds that were significantly associated with the NSC 648365.

NSC Compound Enrichment Correlation
NSC 726267 Null 0.0220039422291539 0.27007017
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0220039422291539 0.29975653
NSC 728035 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di 0.0220039422291539 0.27827373
NSC 733504 Everolimus 0.0220039422291539 -0.05117634
NSC 736802 Null 0.0220039422291539 0.45581389
NSC 737231 Null 0.0220039422291539 0.27709647
NSC 740 Methotrexate 0.0220039422291539 0.53791532
NSC 753769 Null 0.0220039422291539 0.018149965
NSC 759178 Pipamperone 0.0220039422291539 0.29745964
NSC 84074 Phosphonium, (3-bromopropyl)triphenyl- bromide 0.0220039422291539 0.2829555
Total:96  Current:51    [First] [Prev] [Next] [Last]